BLAINJECTIONINJECTABLE
Approved
Mar 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed 20h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
MICROLITE is a radiopharmaceutical diagnostic imaging agent containing Technetium TC-99M bound to albumin colloid particles. It is used for diagnostic imaging procedures to visualize organ function and structure via injection. The product works by targeting the reticuloendothelial system, allowing clinicians to assess liver, spleen, and bone marrow perfusion and function.
LOE Approaching
As an aging diagnostic product approaching loss of exclusivity, the team is likely focused on defending market share against generic/biosimilar competition rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
Started Oct 2005
11 enrolled
Liver Cancer
Career Relevance
Working on MICROLITE offers exposure to diagnostic radiopharmaceutical commercialization, regulatory compliance, and healthcare provider relationships in nuclear medicine. This role is best suited for professionals interested in specialized diagnostic markets and mature product management in a stable, predictable business environment.
Diagnostic Product Manager
Worked on MICROLITE at PharmaLundensis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.